Physical and Genetic Interaction Landscape of the Tyrosine Kinome

酪氨酸激酶的物理和遗传相互作用景观

基本信息

项目摘要

DESCRIPTION (provided by applicant): Signaling by tyrosine kinases play a major role in mammalian signal transduction and is a major component of nearly every major disease type. However, a systematic understanding of signaling pathways has remained elusive. While a number of techniques have been developed to map signaling pathways, used alone they only provide insight into one facet of signaling. We will use an integrative approach to chart the networks which control tyrosine kinase signaling at multiple levels through the use of complementary physical and genetic interaction mapping approaches. These maps will lead to network models which reflect proteins that can functionally modulate signaling and are physically associated with kinases including substrates, adaptors and regulatory subunits. To achieve this, the proposal integrates the complementary expertise of investigators at the University of California-San Francisco in high-throughput physical and genetic interaction mapping (Krogan), chemical-genetic approaches for tracing signaling pathways (Shokat) and network analysis and data integration (Bandyopadhyay). We aim to identify proteins that associate with tyrosine kinases through affinity purification-mass spectrometry (AP-MS) and kinase substrates through covalent capture-and-release in Aim 1. These data will be further characterized using a newly developed platform for quantitative genetic interaction mapping in mammalian cells, which will establish the functional relevance of these interactions by systematically identifying epistatic genetic relationships between kinases and associated proteins in Aim 2. Lastly, in Aim 3, we will unify data collected in the first two aims using network modeling to uncover detailed, mechanistic biological insights relating to mammalian tyrosine kinases. All data (raw, processed and integrated) will be made immediately available in an interactive and searchable fashion so that others can exploit the information we have collected on the tyrosine kinome.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sourav Bandyopadhyay其他文献

Sourav Bandyopadhyay的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sourav Bandyopadhyay', 18)}}的其他基金

Bay Area Cancer Target Discovery and Development
湾区癌症靶标的发现和开发
  • 批准号:
    10704172
  • 财政年份:
    2022
  • 资助金额:
    $ 44.02万
  • 项目类别:
Bay Area Cancer Target Discovery and Development
湾区癌症靶标的发现和开发
  • 批准号:
    10504993
  • 财政年份:
    2022
  • 资助金额:
    $ 44.02万
  • 项目类别:
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
应激反应驱动EGFR突变肺癌的耐药性并塑造肿瘤进化
  • 批准号:
    10329992
  • 财政年份:
    2020
  • 资助金额:
    $ 44.02万
  • 项目类别:
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
应激反应驱动EGFR突变肺癌的耐药性并塑造肿瘤进化
  • 批准号:
    9887321
  • 财政年份:
    2020
  • 资助金额:
    $ 44.02万
  • 项目类别:
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
应激反应驱动EGFR突变肺癌的耐药性并塑造肿瘤进化
  • 批准号:
    10552632
  • 财政年份:
    2020
  • 资助金额:
    $ 44.02万
  • 项目类别:
The Cancer Target Discovery and Development Network at UCSF
加州大学旧金山分校癌症靶标发现和开发网络
  • 批准号:
    9753177
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
Organoid Acquired Resistance
类器官获得性抗性
  • 批准号:
    10517262
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
The Cancer Target Discovery and Development Network at UCSF
加州大学旧金山分校癌症靶标发现和开发网络
  • 批准号:
    10210200
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
Organoid Acquired Resistance
类器官获得性抗性
  • 批准号:
    10705134
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
Physical and Genetic Interaction Landscape of the Tyrosine Kinome
酪氨酸激酶的物理和遗传相互作用景观
  • 批准号:
    8697650
  • 财政年份:
    2014
  • 资助金额:
    $ 44.02万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 44.02万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 44.02万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了